These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 17222691

  • 1. The innate antiviral response: new insights into a continuing story.
    Paun A, Pitha PM.
    Adv Virus Res; 2007; 69():1-66. PubMed ID: 17222691
    [No Abstract] [Full Text] [Related]

  • 2. [Molecular mechanisms for suppression of TLR signaling pathway by virus infection].
    Fujii N, Yokota S, Yokosawa N, Okabayashi T.
    Tanpakushitsu Kakusan Koso; 2008 May; 53(6):710-9. PubMed ID: 18453146
    [No Abstract] [Full Text] [Related]

  • 3. Toll-like receptors and innate antiviral immunity.
    Galiana-Arnoux D, Imler JL.
    Tissue Antigens; 2006 Apr; 67(4):267-76. PubMed ID: 16634862
    [Abstract] [Full Text] [Related]

  • 4. Innate immune response to viral infection.
    Koyama S, Ishii KJ, Coban C, Akira S.
    Cytokine; 2008 Sep; 43(3):336-41. PubMed ID: 18694646
    [Abstract] [Full Text] [Related]

  • 5. [Self or non-self RNA sensing mechanism of innate antiviral immunity].
    Onoguchi K, Yoneyama M.
    Tanpakushitsu Kakusan Koso; 2009 Dec; 54(16 Suppl):2226-32. PubMed ID: 21089645
    [No Abstract] [Full Text] [Related]

  • 6. Innate antiviral immunity of periodontal tissue.
    Mahanonda R, Sa-Ard-Iam N, Rerkyen P, Champaiboon C, Vanavit N, Pichyangkul S.
    Periodontol 2000; 2011 Jun; 56(1):143-53. PubMed ID: 21501241
    [No Abstract] [Full Text] [Related]

  • 7. Immunodeficiency: UNC-93B gets a toll call.
    Conley ME.
    Trends Immunol; 2007 Mar; 28(3):99-101. PubMed ID: 17240194
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Toll-like receptors in Borrelia burgdorferi-induced inflammation.
    Singh SK, Girschick HJ.
    Clin Microbiol Infect; 2006 Aug; 12(8):705-17. PubMed ID: 16842565
    [Abstract] [Full Text] [Related]

  • 10. Viral recognition by Toll-like receptors.
    Barton GM.
    Semin Immunol; 2007 Feb; 19(1):33-40. PubMed ID: 17336545
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.
    Kanzler H, Barrat FJ, Hessel EM, Coffman RL.
    Nat Med; 2007 May; 13(5):552-9. PubMed ID: 17479101
    [Abstract] [Full Text] [Related]

  • 15. Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity.
    Bowie AG.
    Clin Exp Immunol; 2007 Feb; 147(2):217-26. PubMed ID: 17223961
    [Abstract] [Full Text] [Related]

  • 16. Toll-Like receptors (TLRs) and their ligands.
    Uematsu S, Akira S.
    Handb Exp Pharmacol; 2008 Feb; (183):1-20. PubMed ID: 18071652
    [Abstract] [Full Text] [Related]

  • 17. [Toll-like receptors, a new way of treatment?].
    Pedersen CV, Østergaard LJ, Mogensen TH, Paludan SR, Bertelsen LS.
    Ugeskr Laeger; 2007 Jun 04; 169(23):2193-8. PubMed ID: 17592684
    [Abstract] [Full Text] [Related]

  • 18. Signaling to NF-kappaB by Toll-like receptors.
    Kawai T, Akira S.
    Trends Mol Med; 2007 Nov 04; 13(11):460-9. PubMed ID: 18029230
    [Abstract] [Full Text] [Related]

  • 19. [Pathogen recognition by innate immunity].
    Takeuchi O, Akira S.
    Arerugi; 2007 Jun 04; 56(6):558-62. PubMed ID: 17615498
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.